openPR Logo
Press release

HER2 Antibodies Market is Estimated to be Worth US$ 21,669.1 Million by 2025

02-27-2018 04:29 PM CET | Health & Medicine

Press release from: Transparency Market Research

HER2 Antibodies Market is Estimated to be Worth US$ 21,669.1

Among all the chronic diseases worldwide cancer is considered to be the most prevalent disease. Approximately 1,685,210 new cancer cases were diagnosed and about 595,690 cancer deaths in the US in year 2016. Whereas around 2,600 men and 246,660 that is about 29% women were diagnosed with breast cancer in year 2016. HER2 breast cancer is one of the aggressive type of breast cancer, caused due to over-expression of the HER2 protein. Breast cancers that overexpress the HER2 protein (known as HER2+) make up about 20% of the cases.

Request for Sample Copy of Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=7301

HER2 positive breast cancer inclines to grow more rapidly than HER2 negative breast cancer. The factors such as being overweight, long term heavy smoking, use of menopausal hormone therapy, alcohol consumption, physical inactivity and many more are responsible for increasing risk of breast cancer. Increasing incidence of breast cancer is expected to lead to increase in demand for targeted therapies and boost the growth of the HER2 antibodies market during the forecast period.

This report analyzes the current and future prospects of the HER2 antibodies market based on type of treatment drugs and geography. The research is a combination of primary and secondary research, conducted for understanding and arriving at trends, used to forecast the expected revenue of the major HER2 antibody drugs in the near future. Primary research formed the bulk of our research efforts with information collected from in-depth interviews and discussions with a number of key industry experts and opinion leaders.

Enquiry for discount on this report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=7301

Secondary research involved study of company websites, annual reports, press releases, investor presentations, analyst presentation and various international and national databases. The report provides estimated market size in terms of US$ Mn for each type of treatment drug, and geography for the period 2016 to 2025, considering the macro and micro environmental factors. The revenue generated from each drug was calculated by considering number of drugs used in the treatment and their market demand and sales as per their use, number of new drug launched, trends in industry, awareness, and adoption rate across all the geographies. The prevalence of HER2 breast cancer was also considered while estimating the market revenue.

The market report comprises an elaborated executive summary, which includes market snapshot that provides information about various segments of the market. It also provides information and data analysis of the market with respect to market segments based on type of treatment drugs and geography. The market overview section of the report analyzes market dynamics such as drivers, restraints and opportunities that influence the HER2 antibodies market in the current and future scenario. The report also provides pipeline analysis of the upcoming drugs for HER2 breast cancer.

Market share analysis among the market players is analyzed to signify percentage share of the major players operating in the market. All these factors will help the market players to decide about the business strategies and plans to strengthen their positions in the global market. Based on geography, the market has been analyzed for countries of North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Report Overview @ https://www.transparencymarketresearch.com/her2-antibodies-market.html

The report also profiles the major players in the market and provides various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major companies profiled in the HER2 antibodies market report are Genentech Inc. (F. Hoffmann-La Roche Ltd.), Novartis AG, Pfizer, Inc., Abnova Corporation, InvivoGen, Celltrion, Inc., Biocon Limited, and Bio-Techne (Novus Biologicals, LLC) and some other players who are involved in the HER2 antibodies market.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release HER2 Antibodies Market is Estimated to be Worth US$ 21,669.1 Million by 2025 here

News-ID: 959968 • Views: 413

More Releases from Transparency Market Research

Tunnel Boring Machine Market Demand, Insights and Forecast up to 2025
Overview TMR’s report on the Tunnel Boring Machine Market is an all-important tool for stakeholders in their pursuit to discover avenues for innovation, and further undertake strategic planning for the launch of products and services. Our research report on the Tunnel Boring Machine serves as a valuable guide for stakeholders. The report deep dives into demand drivers, challenges, and opportunities that are likely to influence the Tunnel Boring Machine over the
Cellulose Diacetate Films Market Size to Expand Significantly by the End of 2025
Overview TMR’s report on the Cellulose Diacetate Films Market is an all-important tool for stakeholders in their pursuit to discover avenues for innovation, and further undertake strategic planning for the launch of products and services. Our research report on the Cellulose Diacetate Films serves as a valuable guide for stakeholders. The report deep dives into demand drivers, challenges, and opportunities that are likely to influence the Cellulose Diacetate Films over the
Ruthenium Market Projected to Gain Significant Value by 2025
Overview TMR’s report on the Ruthenium Market is an all-important tool for stakeholders in their pursuit to discover avenues for innovation, and further undertake strategic planning for the launch of products and services. Our research report on the Ruthenium serves as a valuable guide for stakeholders. The report deep dives into demand drivers, challenges, and opportunities that are likely to influence the Ruthenium over the forecast period. These indicators help businesses
Pultrusion Market to Reap Excessive Revenues by 2025
Overview TMR’s report on the Pultrusion Market is an all-important tool for stakeholders in their pursuit to discover avenues for innovation, and further undertake strategic planning for the launch of products and services. Our research report on the Pultrusion serves as a valuable guide for stakeholders. The report deep dives into demand drivers, challenges, and opportunities that are likely to influence the Pultrusion over the forecast period. These indicators help businesses

All 5 Releases


More Releases for HER2

HER2 Antibodies Market Expand with Significant CAGR During 2018-2025
Global HER2 Antibodies Market: Overview Among all the chronic diseases worldwide cancer is considered to be the most prevalent disease. Approximately 1,685,210 new cancer cases were diagnosed and about 595,690 cancer deaths in the US in year 2016. Whereas around 2,600 men and 246,660 that is about 29% women were diagnosed with breast cancer in year 2016. HER2 breast cancer is one of the aggressive type of breast cancer, caused due
HER2 Antibodies Market to approach US$ 21,669.1 mn by 2025
A recent market intelligence study by Transparency Market Research (TMR) suggests that the global HER2 antibodies market offers lucrative opportunities as the awareness regarding breast cancer and personalized medicines spreads. Consequently, the competitive landscape of the HER2 antibodies market is already quite intense with the presence of a large number of players, both global and regional. The report identifies Pfizer, Inc., Novartis AG, Genentech Inc. by F. Hoffmann-La Roche Ltd.,
Competitive Dynamics Of HER2 Antibodies Market in Global Industry 2017
Albany, NY, 15th December : Recent research and the current scenario as well as future market potential of "HER2 Antibodies Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025" globally. Among all the chronic diseases worldwide cancer is considered to be the most prevalent disease. Approximately 1,685,210 new cancer cases were diagnosed and about 595,690 cancer deaths in the US in year 2016. Get PDF for more
HER2 Antibodies Market Key Trends and Forecast Research Report 2025
As per the projections of the TMR report, the demand in the global HER2 antibodies market will multiply at an impressive CAGR of 8.6% during the forecast period of 2017 to 2025, achieving an estimated global valuation of US$21,669.1 mn by the end of 2025, substantially up from its evaluated worth of US$10,087.8 mn in 2016. In the near future, new drug development is expected to be based on adjuvant
HER2 Antibodies Market Key Trends and Forecast Research Report 2025
As per the projections of the TMR report, the demand in the global HER2 antibodies market will multiply at an impressive CAGR of 8.6% during the forecast period of 2017 to 2025, achieving an estimated global valuation of US$21,669.1 mn by the end of 2025, substantially up from its evaluated worth of US$10,087.8 mn in 2016. In the near future, new drug development is expected to be based on adjuvant
Her2 Antibodies Market: Industry Overview and Key Factors
Global Her2 Antibodies Market: Overview Human epidermal growth factor receptor 2 (Her2) refers to an oncogene whose over-expression or amplification is commonly associated with the development of an aggressive type of breast cancer. Patients having the over-expression of Her2 receptors are diagnosed with the help of tests such as Fluorescent In-Situ Hybridization (FISH) and Immunohistochemistry (IHC). The American Cancer Society states that around 15-30% of breast cancer cases over-express the Her2